GlassScriptPhysician profile
Hector R Toro
NPI 1114033990
$1,572.46
in general payments reported to CMS, 2019-2025
15 companies · $25.00 in 2025
The $25.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $871 · 2020: $65.00 · 2021: $217 · 2022: $367 · 2024: $26.55 · 2025: $25.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $333.21 | 2019-2022 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $293.55 | 2019-2025 | Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.96 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $130.67 | 2019 | |
| Lilly USA, LLC | $94.49 | 2019 | |
| Pbg Puerto Rico LLC | $86.04 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $75.00 | 2022 | |
| Abbvie INC. | $70.00 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $56.90 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $52.49 | 2019 | |
| Mylan Specialty L.P. | $50.00 | 2019 | |
| Glaxosmithkline, LLC. | $47.39 | 2019-2022 | |
| Novo Nordisk INC | $20.00 | 2020 | |
| Pfizer Pharmaceuticals LLC | $16.76 | 2019 | |
| Abbott Laboratories | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Toro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.